ImpactRx Raises Series E Round
ImpactRx Inc., a Mr. Laurel, N.J.-based developer of a subscription database for pharmaceutical companies, has held a first close on a $1.2 million Series E round from existing shareholders. The company previously raised around $36 million in VC funding from Mediphase Venture Partners, 3i Group, Oxford Bioscience Partners and Merck Capital Ventures.
11 January 2010•2 mins read
